Critical illnesses have a significant impact on overall survival among patients with cancer
the ONA take:
A new study from researchers at the University of Glasgow found 1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis, and a quarter of them died in hospital. In addition, this risk increased with age.
Using cancer registry and hospital data from Scotland spanning 10 years, the researchers captured information on more than 118,500 people with cancer, including 6,116 who were admitted to ICU.
Study findings showed that risk of ICU admission was highest among patients with GI cancer and lowest in patients with prostate cancer, breast cancer, and melanoma of the skin.
Mortality was higher among emergency medical admissions, and those who received organ support compared with those who did not receive organ support.
Deaths during hospital stays was higher among patients with cancers of unknown primary cause, lung cancer, and liver cancer, but those with head and neck cancers, multiple cancers, kidney cancer, and thyroid cancer had lower mortality rates.
The study indicates that critical illness may play a role in overall cancer outcomes. The researchers suggest that if ICUs can effectively reduce the risk of dying following a critical illness, increased surveillance for early signs of critical illness and access to ICU care for patients with cancer may improve overall survival rates.
1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Neuropathic Cancer Pain Linked to Reduced Quality of Life
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|